<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00758537</url>
  </required_header>
  <id_info>
    <org_study_id>TRY1STU</org_study_id>
    <nct_id>NCT00758537</nct_id>
  </id_info>
  <brief_title>Tryptophan Metabolism in Kidney Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <brief_summary>
    <textblock>
      Tryptophan metabolism in kidney disease will be investigated in patients with chronic kidney
      disease stages (ADOQI 3-5). Tryptophan levels and respective catabolites will be assessed
      under hemodialysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date>October 2008</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Course of plasma tryptophan level and levels of tryptophan metabolites under standard low-flux hemodialysis.</measure>
    <time_frame>does not apply</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Patients with chronic kidney disease stage 3</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with chronic kidney disease stage 4</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with chronic kidney disease stage 5 (ESRD)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls (no kidney disease)</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        tertiary care academic center, university hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic kidney disease (for &gt; 3months) stages (National Kidney foundation/ADOQI): 3-5

        Exclusion Criteria:

          -  Signs of infection or systemic inflammation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petra Reinke, Md PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charite University Medicine Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2008</study_first_submitted>
  <study_first_submitted_qc>September 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2008</study_first_posted>
  <last_update_submitted>July 13, 2009</last_update_submitted>
  <last_update_submitted_qc>July 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Petra Reinke MD</name_title>
    <organization>Charite UNiversity Medicine Berlin, Germany</organization>
  </responsible_party>
  <keyword>Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tryptophan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

